From: Pelvic exenteration in gynecologic cancer: complications and oncological outcome
Hospitalisation stay (days) [Mean ± SD (range)] | 22.9 ± 15.9 (7–72) |
ICU stay [n (%)] | 2.2 ± 1.5 (1–5) |
Re- surgery [n (%)] | 4 (17) |
TPN [n (%)] | 10 (43) |
Patients with transfusion [n (%)] | 11 (48) |
Transfusion (Units) [Mean ± SD (range)] | 1.96 ± 2.7 (1–10) |
Circulatory event [n (%)] | |
Thromboembolism | 0 (0) |
Cardiovascular event | 0 (0) |
Urinary [n (%)] | |
No | 19 (83) |
Ureter leakage | 2 (9) |
Urostomy complication | 1 (4) |
Renal failure | 3 (13) |
Gastrointestinal [n (%)] | |
Paralytic ileus | 6 (26) |
Leakage | 0 (0) |
Wound [n (%)] | |
No | 15 (65) |
Dehiscence | 7 (30) |
Infection | 5 (22) |
Haematoma | 1 (4) |
Flap necrosis | 1 (4) |
Lymphorrea | 1 (4) |
Infectious [n (%)] | |
No | 17 (74) |
Abscess | 2 (9) |
Fever and bacteremia | 3 (13) |
Sepsis | 1 (4) |
Respiratory [n (%)] | |
Infectious | 0 (0) |
Respiratory insufficiency | 1 (4) |
Others [n (%)] | |
Motor dysfunction | 1 (4) |
Clavien Dindo [Mean ± SD (range)] | |
Grade II | 1.8 ± 1.6 (0–5) |
Grade III | 0.3 ± 0.5 (0–2) |
Grade IV | 0.1 ± 0.53 (0–1) |
Grade V | 0 ± (0–0) |
Patients with complication [n (%)] | 5 (22) |
Grade II | 15 (65) |
Grade III | 5 (22) |
Grade IV | 2 (9) |
Grade V | 0 (0) |